BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 12694570)

  • 1. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
    Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
    Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers.
    Kloor M; Becker C; Benner A; Woerner SM; Gebert J; Ferrone S; von Knebel Doeberitz M
    Cancer Res; 2005 Jul; 65(14):6418-24. PubMed ID: 16024646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
    Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
    Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
    Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
    Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
    Hoves S; Aigner M; Pfeiffer C; Laumer M; Obermann EC; Mackensen A
    Leukemia; 2009 May; 23(5):877-85. PubMed ID: 19148137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.
    Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of mouse anti-human LMP2, LMP7, TAP1 and TAP2 monoclonal antibodies.
    Kishore R; Hicklin DJ; Dellaratta DV; Golde U; Kageshita T; Seliger B; Ferrone S
    Tissue Antigens; 1998 Feb; 51(2):129-40. PubMed ID: 9510369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases.
    Müller M; Agaimy A; Zenk J; Ettl T; Iro H; Hartmann A; Seliger B; Schwarz S
    Histopathology; 2013 May; 62(6):847-59. PubMed ID: 23611358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.
    de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H
    J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.
    Kamarashev J; Ferrone S; Seifert B; Böni R; Nestle FO; Burg G; Dummer R
    Int J Cancer; 2001 Jan; 95(1):23-8. PubMed ID: 11241306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
    Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.